|
|
Blood, 15 September 2008, Vol. 112, No. 6, pp. 2421-2428.
Prepublished online as a Blood First Edition Paper on January 11, 2008; DOI 10.1182/blood-2007-11-123513.
Previous Article | Next Article 
Submitted November 14, 2007
Accepted January 5, 2008
Multiple ITAM-coupled NK cell receptors engage the Bcl10/Malt1 complex via Carma1 for NF- B and MAPK activation to selectively control cytokine production
Olaf Gross, Christina Grupp, Christian Steinberg, Stephanie Zimmermann, Dominikus Strasser, Nicole Hannesschlager, Wolfgang Reindl, Helena Jonsson, Hairong Huo, Dan R. Littman, Christian Peschel, Wayne M. Yokoyama, Anne Krug, and Jurgen Ruland*
III. Medizinische Klinik, Klinikum rechts der Isar, Technische Universitat Munchen, Munich, Germany
II. Medizinische Klinik, Klinikum rechts der Isar, Technische Universitat Munchen, Munich, Germany
Rheumatology Division, Department of Medicine, Howard Hughes Medical Institute, Washington University School of Medicine, St. Louis, MO, United States
Molecular Pathogenesis Program, Skirball Institute of Biomolecular Medicine, New York University School of Medicine, New York, NY, United States
* Corresponding author; email: jruland{at}lrz.tu-muenchen.de.
Natural Killer (NK) cells are innate immune cells that mediate resistance against viruses and tumors. They express multiple activating receptors that couple to immunoreceptor tyrosine-based activation motif (ITAM) containing signaling chains for downstream cell activation. Ligation of activating NK cell receptors induces NK cell cytotoxicity and cytokine release. How these distinct events are selectively controlled is not well defined.
Here we report the identification of a specific signaling pathway that operates downstream of the ITAM coupled NK cell receptors NK1.1, Ly49D, Ly49H and NKG2D. Using primary NK cells from Bcl10-/-, Malt1-/-, Carma1-/-, and Card9-/- mice we demonstrate a key role for Bcl10 signalosomes in the activation of canonical NF- B signaling as well as JNK and p38 MAPK upon NK cell triggering. Bcl10 directly cooperates with Malt1 and depends on Carma1 (Card11) but not on Card9 for NK cell activation. These Bcl10-dependent cascades selectively control cytokine and chemokine production but do not affect NK cell differentiation or killing. Thus, we identify a molecular basis for the segregation of NK cell receptor induced signals for cytokine release and target cell killing and extend the previously recognized roles for CARD-protein/Bcl10/Malt1 complexes in ITAM receptor signaling in innate and adaptive immune cells.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S. Hailfinger, G. Lenz, V. Ngo, A. Posvitz-Fejfar, F. Rebeaud, M. Guzzardi, E.-M. M. Penas, J. Dierlamm, W. C. Chan, L. M. Staudt, et al.
Essential role of MALT1 protease activity in activated B cell-like diffuse large B-cell lymphoma
PNAS,
November 24, 2009;
106(47):
19946 - 19951.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Robinson, F. Osorio, M. Rosas, R. P. Freitas, E. Schweighoffer, O. Gross, J. S. Verbeek, J. Ruland, V. Tybulewicz, G. D. Brown, et al.
Dectin-2 is a Syk-coupled pattern recognition receptor crucial for Th17 responses to fungal infection
J. Exp. Med.,
August 31, 2009;
206(9):
2037 - 2051.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. D. Langel, N. A. Jain, J. S. Rossman, L. M. Kingeter, A. K. Kashyap, and B. C. Schaefer
Multiple Protein Domains Mediate Interaction between Bcl10 and MALT1
J. Biol. Chem.,
November 21, 2008;
283(47):
32419 - 32431.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Tassi, M. Cella, R. Presti, A. Colucci, S. Gilfillan, D. R. Littman, and M. Colonna
NK cell-activating receptors require PKC-{theta} for sustained signaling, transcriptional activation, and IFN-{gamma} secretion
Blood,
November 15, 2008;
112(10):
4109 - 4116.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Guo, A. Samarakoon, B. Vanhaesebroeck, and S. Malarkannan
The p110{delta} of PI3K plays a critical role in NK cell terminal maturation and cytokine/chemokine generation
J. Exp. Med.,
September 29, 2008;
205(10):
2419 - 2435.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|